Abstract

You have accessJournal of UrologyCME1 Apr 2023MP60-04 CANNABIS USE IS A PREDICTOR OF HIGHER RATES OF URINARY INCONTINENCE IN BOTH MALES AND FEMALES; ANALYSIS OF THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY Micah Levy, Christopher Connors, Chih Peng Chin, Krishna T. Ravivarapu, Olamide O. Omidele, and Michael A. Palese Micah LevyMicah Levy More articles by this author , Christopher ConnorsChristopher Connors More articles by this author , Chih Peng ChinChih Peng Chin More articles by this author , Krishna T. RavivarapuKrishna T. Ravivarapu More articles by this author , Olamide O. OmideleOlamide O. Omidele More articles by this author , and Michael A. PaleseMichael A. Palese More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003318.04AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: There is little research exploring the possible association between cannabis use and urinary incontinence (UI). With cannabis legalization on the rise in the United States, it is important to understand how it may impact patients. We identified the impact of cannabis use on the rate and severity of urinary incontinence in male and female populations. METHODS: The National Health and Nutrition Examination Survey (NHANES) was queried from 2013-2018. Respondents were grouped as either using or never using cannabis. The rate of UI and UI subtypes (stress, urge, and overflow) were analyzed based on cannabis use. Symptom frequency was analyzed, with moderate symptoms defined as UI occurring less than once a week, and severe symptoms defined as UI occurring at least once a week. Multivariate analysis including age, race, education, income to poverty ratio, BMI, cigarette use, and parity was used to determine whether cannabis use is an independent predictor of UI. RESULTS: 3,391 males (1,506 [44.4%] used cannabis) and 3,570 females (987 [27.6%] used cannabis) were included in analysis. Cannabis use was associated with a greater rate of urinary incontinence in both males (13% vs. 7%, p<0.001) and females (42% vs. 34%, p<0.001). It was associated with greater rates of all three types of UI; stress UI in males (4% vs. 2%, p<0.001) and females (42% vs. 36%, p=0.008), urge UI in males (12% vs. 7%, p<0.001) and females (28% vs. 19%, p<0.001), and overflow UI in males (3% vs. 2%, p=0.017) and females (11% vs. 6%, p<0.001). Cannabis use was also associated with more severe symptom frequency in females (37% vs. 29%, p=0.009), but there was no difference in symptom frequency in males. Multivariate analysis showed cannabis to be a significant predictor of UI in both males (OR: 2.04, p<0.001) and in females (OR: 1.65, p=0.003) when controlling for other demographic variables. CONCLUSIONS: Cannabis use is an independent predictor of higher rates of urinary incontinence in both males and females and is associated with higher rates of all forms of urinary incontinence in males and females and with more frequent symptoms in females. With legal cannabis use on the rise, it is important to understand how it may affect the rate and severity of urinary incontinence in patients. Source of Funding: NA © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e843 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Micah Levy More articles by this author Christopher Connors More articles by this author Chih Peng Chin More articles by this author Krishna T. Ravivarapu More articles by this author Olamide O. Omidele More articles by this author Michael A. Palese More articles by this author Expand All Advertisement PDF downloadLoading ...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call